Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK2R Cancer Theranostic Agents: A Preclinical Study is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK069575; R01DK122332
Greek General Secretariat for Research and Technology and the European Regional Development Fund under the Action "Development Grants for Research Institutions
Grant: KRIPIS" of OPCE II
Greek General Secretariat for Research and Technology and the European Regional Development Fund under the Action “Development Grants for Research Institutions
Grant: KRIPIS” of OPCE II
National Institutes of Health
Grant: 5R01DK069575-04
Molecular Basis of Antidiabetogenic Hormone Action
National Institutes of Health
Grant: 1R01DK122332-01A1
Alpha7 Nicotinic Acetylcholine Receptor Regulation of Glucagon-Like Peptide- 1 Incretin Hormone Action.
General Secretariat of Research and Innovation (GSRI)
Grant: unidentified
unidentified
Fields of Study
Keywords
Sustainable Development Goals